Fruebis; Joachim

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fruebis; Joachim.The latest application filed is for "compositions and methods for counteracting factor xa inhibition".

Company Profile

3.8.19

Fruebis; Joachim - Bedford MA
Fruebis; Joachim - Chester NJ
Fruebis; Joachim - Redmond WA
Fruebis; Joachim - Cardiff CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Counteracting Factor Xa Inhibition App 20210000930 - Pittman; Debra D. ; et al.	2021-01-07
Compositions and methods for counteracting Factor Xa inhibition Grant 10,588,950 - Pittman , et al.	2020-03-17
Compositions And Methods For Treating Intracerebral Hemorrhage App 20190231856 - Arkin; Steven ; et al.	2019-08-01
Compositions And Methods For Counteracting Factor Xa Inhibition App 20180344819 - Pittman; Debra D. ; et al.	2018-12-06
Compositions And Methods For Treating Intracerebral Hemorrhage App 20160375109 - Arkin; Steven ; et al.	2016-12-29
Compositions And Methods For Counteracting Factor Xa Inhibition App 20150343034 - Pittman; Debra D. ; et al.	2015-12-03
OBG3 globular head and uses thereof Grant 7,671,024 - Fruebis , et al. March 2, 2	2010-03-02
OBG3 Globular Head and Uses Thereof App 20090099076 - Fruebis; Joachim ; et al.	2009-04-16
Isolated polypeptide comprising a leptin fragment Grant 7,470,669 - Yen , et al. December 30, 2	2008-12-30
Use of ACRP30 Globular Head to Promote Increases in Muscle Mass and Muscle Differentiation App 20080274971 - Lodish; Harvey ; et al.	2008-11-06
Prok2 Antagonists And Methods Of Use App 20080219985 - Thompson; Penny J. ; et al.	2008-09-11
Use of Acrp30 globular head to promote increases in muscle mass and muscle differentiation Grant 7,405,193 - Lodish , et al. July 29, 2	2008-07-29
Nucleic acids encoding OBG3 polypeptides Grant 7,393,661 - Fruebis , et al. July 1, 2	2008-07-01
Nucleic acids encoding OBG3 globular head and uses thereof Grant 7,338,787 - Fruebis , et al. March 4, 2	2008-03-04
OBG3 globular head and uses thereof App 20070275891 - Fruebis; Joachim ; et al.	2007-11-29
Inhibitors for use in hemostasis App 20060252692 - Lasser; Gerald W. ; et al.	2006-11-09
Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation App 20060035824 - Lodish; Harvey ; et al.	2006-02-16
Methods of screening for compounds that modulate the LSR-leptin interaction and their use in the prevention and treatment of obesity-related diseases App 20060030530 - Yen; Frances ; et al.	2006-02-09
OBG3 globular head and uses thereof Grant 6,989,367 - Fruebis , et al. January 24, 2	2006-01-24
OBG3 globular head and uses thereof for decreasing body mass Grant 6,967,091 - Fruebis , et al. November 22, 2	2005-11-22
OBG3 globular head and uses thereof App 20050059631 - Fruebis, Joachim ; et al.	2005-03-17
OBG3 globular head and uses thereof App 20040067881 - Fruebis, Joachim ; et al.	2004-04-08
Inhibitors for use in hemostasis App 20030220253 - Lasser, Gerald W. ; et al.	2003-11-27
OBG3 globular head and uses thereof for decreasing body mass App 20030100500 - Fruebis, Joachim ; et al.	2003-05-29
OBG3 globular head and uses thereof for decreasing body mass App 20020091080 - Fruebis, Joachim ; et al.	2002-07-11
OBG3 globular head and uses thereof for decreasing body mass App 20020058617 - Fruebis, Joachim ; et al.	2002-05-16
OBG3 globular head and uses thereof for decreasing body mass App 20020037849 - Fruebis, Joachim ; et al.	2002-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.